PPARGC1A and chronic kidney disease: As shown in Fig. 8, cardiac hypertrophy and failure, PGC1α downregulation, and energy metabolism remodeling in HPD-fed CKD mice were significantly ameliorated by knocking down IRF1 expression in IRF+/− mice (Fig. 8a–h).